Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma Journal Article
| Authors: | Wells, S. A.; Asa, S. L.; Dralle, H.; Elisei, R.; Evans, D. B.; Gagel, R. F.; Lee, N.; MacHens, A.; Moley, J. F.; Pacini, F.; Raue, F.; Frank-Raue, K.; Robinson, B.; Rosenthal, M. S.; Santoro, M.; Schlumberger, M.; Shah, M.; Waguespack, S. G. |
| Article Title: | Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma |
| Abstract: | Introduction: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. Methods: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document. Results: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC. Conclusions: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice. © 2015 Mary Ann Liebert, Inc. |
| Keywords: | systemic therapy; united states; bone metastasis; cancer patient; cancer diagnosis; evidence based medicine; cancer palliative therapy; carcinoembryonic antigen; calcitonin; practice guideline; cancer therapy; protein tyrosine kinase inhibitor; patient care; liver metastasis; lung metastasis; vandetanib; medical society; thyroidectomy; medical practice; genetic screening; dna determination; skin metastasis; hormone substitution; mediastinum metastasis; thyroid medullary carcinoma; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); oncogene ret; fine needle aspiration biopsy; germline mutation; cabozantinib; human; priority journal; article |
| Journal Title: | Thyroid |
| Volume: | 25 |
| Issue: | 6 |
| ISSN: | 1050-7256 |
| Publisher: | Mary Ann Liebert, Inc |
| Date Published: | 2015-06-01 |
| Start Page: | 567 |
| End Page: | 610 |
| Language: | English |
| DOI: | 10.1089/thy.2014.0335 |
| PROVIDER: | scopus |
| PUBMED: | 25810047 |
| PMCID: | PMC4490627 |
| DOI/URL: | |
| Notes: | Export Date: 2 July 2015 -- Source: Scopus |
